Prudential Financial
ADVM

Prudential Financial’s Adverum Biotechnologies ADVM Stock Holding History

Prudential Financial’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,367
Closed -$376K – 2628
2021
Q3 		$376K Buy
17,367
+12,219
+237% +$312K ﹤0.01% 2243
2021
Q2 		$180K Buy
+5,148
New +$277K ﹤0.01% 2463

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Prudential Financial's ADVM Position: Q4 2021 in Review

Prudential Financial sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 17,367 shares — an estimated $376K sold.

Prudential Financial first reported a position in ADVM in Q2 2021 and held it in 2 quarters. The position peaked at $376K in Q3 2021. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • Prudential Financial reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • Prudential Financial sold 17,367 Adverum Biotechnologies shares in Q4 2021, an estimated $376K.
  • Prudential Financial first reported a position in Adverum Biotechnologies in Q2 2021 and held it in 2 quarters.
  • Prudential Financial's Adverum Biotechnologies position peaked at $376K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.